News Snapshot:
China grants country’s first Covid-19 vaccine patent to CanSino: Report – News August 17, 2020 Source link Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. China’s vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its Covid-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country’s intellectual property regulator. It is the first Covid-19 vaccine patent granted by China, state-owned newspaper People’s Daily reported on Sunday. The paper cited documents published by China’s National Intellectual Property Administration saying that the patent was issued on August...
